MedTrace Logo

The Altura Abdominal Aortic Aneurysm (AAA) Endograft Safety and Feasibility Study

NCT01346943 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-01-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety of deploying and implanting the Altura Abdominal Aortic Aneurysm (AAA) Endograft in the treatment of abdominal aortic aneurysms in subjects who are candidates for open surgical aneurysm repair.

Conditions

  • Abdominal Aortic Aneurysms

Interventions

DEVICE

Altura Medical Abdominal Aortic Aneurysm Stent-Graft

Altura Medical AAA Stent Graft System

Sponsors & Collaborators

  • Altura Medical Inc.

    lead INDUSTRY

Principal Investigators

  • Albrecht Kramer, MD · Pontificia Universidad Catolica de Chile

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • Chile
  • Latvia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01346943 on ClinicalTrials.gov